Geneos Wealth Management’s Invesco S&P 500 BuyWrite ETF PBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-500
Closed -$10.6K 2103
2023
Q1
$10.6K Hold
500
﹤0.01% 1535
2022
Q4
$10.1K Hold
500
﹤0.01% 1529
2022
Q3
$9K Hold
500
﹤0.01% 1547
2022
Q2
$10K Hold
500
﹤0.01% 1950
2022
Q1
$11K Hold
500
﹤0.01% 2058
2021
Q4
$11K Hold
500
﹤0.01% 2148
2021
Q3
$11K Hold
500
﹤0.01% 2188
2021
Q2
$11K Hold
500
﹤0.01% 2168
2021
Q1
$10K Hold
500
﹤0.01% 2389
2020
Q4
$10K Hold
500
﹤0.01% 2222
2020
Q3
$9K Hold
500
﹤0.01% 1990
2020
Q2
$8K Sell
500
-300
-38% -$5.29K ﹤0.01% 1987
2020
Q1
$13K Sell
800
-600
-43% -$12.1K ﹤0.01% 1698
2019
Q4
$30K Hold
1,400
﹤0.01% 1506
2019
Q3
$30K Sell
1,400
-402
-22% -$8.72K ﹤0.01% 1429
2019
Q2
$39K Hold
1,802
﹤0.01% 1318
2019
Q1
$37K Sell
1,802
-1,150
-39% -$23.6K ﹤0.01% 1290
2018
Q4
$57K Hold
2,952
﹤0.01% 1034
2018
Q3
$66K Hold
2,952
﹤0.01% 1050
2018
Q2
$63K Buy
+2,952
New +$63.6K ﹤0.01% 948

Other funds holding PBP

Geneos Wealth Management's PBP Position: Q2 2023 in Review

Geneos Wealth Management sold out of Invesco S&P 500 BuyWrite ETF (PBP) in Q2 2023, closing a stake of 500 shares — an estimated $10.6K sold.

Geneos Wealth Management first reported a position in PBP in Q2 2018 and held it in 20 quarters. The position peaked at $66K in Q3 2018. 48 funds tracked by Wall St. Rank hold PBP as of Q2 2023.

  • Geneos Wealth Management reported no remaining Invesco S&P 500 BuyWrite ETF position as of Q2 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 500 Invesco S&P 500 BuyWrite ETF shares in Q2 2023, an estimated $10.6K.
  • Geneos Wealth Management first reported a position in Invesco S&P 500 BuyWrite ETF in Q2 2018 and held it in 20 quarters.
  • Geneos Wealth Management's Invesco S&P 500 BuyWrite ETF position peaked at $66K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held Invesco S&P 500 BuyWrite ETF as of Q2 2023.

Based on Geneos Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.